As the knockdown efficiency of TXNDC5 was low in HEK293T cells and plasmids and transfection efficiency was extremely low in siRNA-transfected hepatoma cells, we selected A549 cells for the next study. Here, TXNDC5 is linked to hepatocellular carcinoma.